Click to Share
  1. Latest News
  2. Submit Press Release
Filter News
Show All Results
News By Country
None Found
News By Tag
Sanofi Company Remove

November 2015
Su Sa Fr Th We Tu Mo
29 28 27 26 25 24 23

Sanofi Company Press Releases


By Mary Ann Liebert, Inc., publishers
By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease.

Page updated every 10 minutes

Like PRLog?
Click to Share